488 related articles for article (PubMed ID: 1538193)
1. Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice.
Wild TF; Bernard A; Spehner D; Drillien R
J Gen Virol; 1992 Feb; 73 ( Pt 2)():359-67. PubMed ID: 1538193
[TBL] [Abstract][Full Text] [Related]
2. Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge.
Taylor J; Pincus S; Tartaglia J; Richardson C; Alkhatib G; Briedis D; Appel M; Norton E; Paoletti E
J Virol; 1991 Aug; 65(8):4263-74. PubMed ID: 1830113
[TBL] [Abstract][Full Text] [Related]
3. Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein.
Drillien R; Spehner D; Kirn A; Giraudon P; Buckland R; Wild F; Lecocq JP
Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1252-6. PubMed ID: 3422488
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of mice against canine distemper virus-induced encephalitis with vaccinia virus recombinants encoding measles or canine distemper virus antigens.
Wild TF; Bernard A; Spehner D; Villeval D; Drillien R
Vaccine; 1993; 11(4):438-44. PubMed ID: 8470428
[TBL] [Abstract][Full Text] [Related]
5. Passively administered antibody suppresses the induction of measles virus antibodies by vaccinia-measles recombinant viruses.
Galletti R; Beauverger P; Wild TF
Vaccine; 1995 Feb; 13(2):197-201. PubMed ID: 7625116
[TBL] [Abstract][Full Text] [Related]
6. Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents.
Fooks AR; Jeevarajah D; Lee J; Warnes A; Niewiesk S; ter Meulen V; Stephenson JR; Clegg JC
J Gen Virol; 1998 May; 79 ( Pt 5)():1027-31. PubMed ID: 9603317
[TBL] [Abstract][Full Text] [Related]
7. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM
J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946
[TBL] [Abstract][Full Text] [Related]
8. Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein of influenza virus.
Endo A; Itamura S; Iinuma H; Funahashi S; Shida H; Koide F; Nerome K; Oya A
J Gen Virol; 1991 Mar; 72 ( Pt 3)():699-703. PubMed ID: 2005435
[TBL] [Abstract][Full Text] [Related]
9. Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity.
Cardoso AI; Blixenkrone-Moller M; Fayolle J; Liu M; Buckland R; Wild TF
Virology; 1996 Nov; 225(2):293-9. PubMed ID: 8918915
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the contribution of CTL epitopes in the immunobiology of morbillivirus infection.
Beauverger P; Cardoso AI; Daviet L; Buckland R; Wild TF
Virology; 1996 May; 219(1):133-9. PubMed ID: 8623522
[TBL] [Abstract][Full Text] [Related]
11. Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins.
Taylor J; Weinberg R; Tartaglia J; Richardson C; Alkhatib G; Briedis D; Appel M; Norton E; Paoletti E
Virology; 1992 Mar; 187(1):321-8. PubMed ID: 1736535
[TBL] [Abstract][Full Text] [Related]
12. High-level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: induction of an MHC-1-restricted CTL response and protection in a murine model.
Fooks AR; Schadeck E; Liebert UG; Dowsett AB; Rima BK; Steward M; Stephenson JR; Wilkinson GW
Virology; 1995 Jul; 210(2):456-65. PubMed ID: 7618280
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus.
Oh S; Stegman B; Pendleton CD; Ota MO; Pan CH; Griffin DE; Burke DS; Berzofsky JA
Virology; 2006 Sep; 352(2):390-9. PubMed ID: 16781760
[TBL] [Abstract][Full Text] [Related]
14. Mucosal and systemic immune responses to measles virus haemagglutinin in mice immunized with a recombinant vaccinia virus.
Etchart N; Wild F; Kaiserlian D
J Gen Virol; 1996 Oct; 77 ( Pt 10)():2471-8. PubMed ID: 8887480
[TBL] [Abstract][Full Text] [Related]
15. The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants.
Andrew ME; Coupar BE; Boyle DB; Ada GL
Scand J Immunol; 1987 Jan; 25(1):21-8. PubMed ID: 3492756
[TBL] [Abstract][Full Text] [Related]
16. Expression of measles virus antigens in Streptococcus gordonii.
Maggi T; Oggioni MR; Medaglini D; Bianchi Bandinelli ML; Soldateschi D; Wiesmüller KH; Muller CP; Valensin PE; Pozzi G
New Microbiol; 2000 Apr; 23(2):119-28. PubMed ID: 10872681
[TBL] [Abstract][Full Text] [Related]
17. Induction of adult-like antibody, Th1, and CTL responses to measles hemagglutinin by early life murine immunization with an attenuated vaccinia-derived NYVAC(K1L) viral vector.
Kovarik J; Gaillard M; Martinez X; Bozzotti P; Lambert PH; Wild TF; Siegrist CA
Virology; 2001 Jun; 285(1):12-20. PubMed ID: 11414801
[TBL] [Abstract][Full Text] [Related]
18. Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants.
Andrew ME; Coupar BE; Ada GL; Boyle DB
Microb Pathog; 1986 Oct; 1(5):443-52. PubMed ID: 3509883
[TBL] [Abstract][Full Text] [Related]
19. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
[TBL] [Abstract][Full Text] [Related]
20. Protection of cattle against rinderpest with vaccinia virus recombinants expressing the HA or F gene.
Yilma T; Hsu D; Jones L; Owens S; Grubman M; Mebus C; Yamanaka M; Dale B
Science; 1988 Nov; 242(4881):1058-61. PubMed ID: 3194758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
